布莱斯特烯C通过多种信号通路对三阴性乳腺癌产生抑制作用
Junsha An1,2, Mingyu Han1, Hailin Tang3
1West China School of Pharmacy, Sichuan University, Chengdu, China.
Frontiers in pharmacology
|November 6, 2024
概括
布莱斯特烯C (BC) 通过向Ras/ERK/c-Fos通路,促进细胞亡,并阻止细胞周期进展,有效地抑制三阴性乳腺癌 (TNBC). 这种天然化合物显示出作为安全有效的抗TNBC治疗剂的希望.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 三重阴性乳腺癌 (TNBC) 由于转移率高和死亡率高,因此存在重大治疗挑战.
- 对于具有更好的疗效和安全性配置的新型抗TNBC药物有着至关重要的需求.
- 布莱斯特烯C (BC) 被确定为一种潜在的治疗剂,对TNBC细胞具有抑制作用.
研究的目的:
- 通过网络药理学和实验验证,研究布莱斯特烯C (BC) 的抗TNBC机制.
- 确定TNBC治疗中受BC影响的关键分子标和途径.
- 在体外和体外TNBC模型中评估BC的疗效和安全性.
主要方法:
- 网络药理学被用来预测TNBC中的活性成分和枢纽目标.
- 试验室研究包括CCK-8,细胞亡,细胞循环,伤口愈合和西部斑点测试.
- 在体内,使用小鼠皮下瘤模型评估疗效,并通过分子对接分析进行补充.
主要成果:
- 布莱斯特烯C (BC) 被确定为主要活性成分,抑制Ras/ERK/c-Fos信号通路.
- BC促进了细胞亡,诱导了S相细胞循环停止,并抑制了BT549 TNBC细胞的增殖和迁移.
- 在体内研究表明,BC在TNBC模型中的瘤生长抑制具有良好的安全性.
结论:
- 布莱斯特烯C (BC) 通过调节Ras/ERK/c-Fos通路并诱导细胞亡和细胞循环停止,有效地抑制TNBC的增殖和迁移.
- 这些发现支持BC作为三阴性乳腺癌的潜在新型治疗剂.
- 这项研究将网络药理与实验数据相结合,以阐明BC的抗TNBC机制.
更多相关视频
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
8.2K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.8K
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
